1. Home
  2. NTZ vs XLO Comparison

NTZ vs XLO Comparison

Compare NTZ & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTZ
  • XLO
  • Stock Information
  • Founded
  • NTZ 1959
  • XLO 2016
  • Country
  • NTZ Italy
  • XLO United States
  • Employees
  • NTZ N/A
  • XLO N/A
  • Industry
  • NTZ Home Furnishings
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTZ Consumer Discretionary
  • XLO Health Care
  • Exchange
  • NTZ Nasdaq
  • XLO Nasdaq
  • Market Cap
  • NTZ 31.2M
  • XLO 35.7M
  • IPO Year
  • NTZ 1993
  • XLO 2021
  • Fundamental
  • Price
  • NTZ $2.92
  • XLO $0.70
  • Analyst Decision
  • NTZ
  • XLO Buy
  • Analyst Count
  • NTZ 0
  • XLO 2
  • Target Price
  • NTZ N/A
  • XLO $3.00
  • AVG Volume (30 Days)
  • NTZ 7.3K
  • XLO 426.8K
  • Earning Date
  • NTZ 10-21-2025
  • XLO 08-14-2025
  • Dividend Yield
  • NTZ N/A
  • XLO N/A
  • EPS Growth
  • NTZ N/A
  • XLO N/A
  • EPS
  • NTZ N/A
  • XLO N/A
  • Revenue
  • NTZ $337,653,480.00
  • XLO $15,001,000.00
  • Revenue This Year
  • NTZ N/A
  • XLO $982.12
  • Revenue Next Year
  • NTZ N/A
  • XLO N/A
  • P/E Ratio
  • NTZ N/A
  • XLO N/A
  • Revenue Growth
  • NTZ N/A
  • XLO 536.45
  • 52 Week Low
  • NTZ $2.15
  • XLO $0.62
  • 52 Week High
  • NTZ $6.27
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • NTZ 50.04
  • XLO 54.07
  • Support Level
  • NTZ $2.70
  • XLO $0.67
  • Resistance Level
  • NTZ $3.07
  • XLO $0.71
  • Average True Range (ATR)
  • NTZ 0.15
  • XLO 0.03
  • MACD
  • NTZ 0.04
  • XLO 0.00
  • Stochastic Oscillator
  • NTZ 39.81
  • XLO 71.57

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: